New York
Dr. Khushbu Shah is a life sciences patent litigator with deep technical and legal expertise spanning small molecules and biologics. She represents leading pharmaceutical and biotechnology innovators in high-stakes U.S. litigation and complex multi-jurisdictional patent disputes.
Dr. Shah possesses in-depth technical knowledge of biologics and their development. Combined with her training in formulations and doctoral training in medicinal chemistry, where she synthesized and characterized dozens of novel compounds including Pemetrexed analogues, she brings a scientist’s precision to patent litigation strategy. Her scientific background informs her understanding of both chemical and biological inventions, from synthesizing complex small molecules and peptides to analyzing antibody sequences and gene therapy vectors.
She has been part of litigation teams that have successfully defended major biopharma clients against coordinated challenges by multiple generic manufacturers to patents protecting multi-billion-dollar blockbuster therapies. Her practice also includes advising on pre-litigation patent strategy, conducting freedom-to-operate and validity analyses, and coordinating worldwide opposition and defense campaigns for products at all stages of development. She has counseled on complex patent landscapes for CAR-T therapies, gene therapy products, and other cutting-edge biologics.
Austin
Adil Shaikh is an experienced patent litigator, adept at handling cases from their initial phases through to trial. With appearances in over 120 cases, he consistently strives to achieve the best possible outcomes for his clients in every engagement.
With extensive technical knowledge and experience, Adil offers invaluable insights and assistance in intellectual property cases. As a former software engineer, he possesses a unique ability to understand clients' innovations, communicate effectively with inventors, scientists, and expert witnesses, and explain complex technologies in clear, comprehensible terms. His practice focuses on patents, particularly in complex software technology and semiconductors.
Before transitioning to the legal industry, Adil held software engineering roles at Sabre Corporation, specializing in data engineering and big data systems. He also gained experience in software development at Nokia Corp and Cisco Systems. Additionally, Adil co-founded a company dedicated to technical education and recruitment.
Washington, D.C.
As part of her practice, Evgeniya advises clients on economic sanctions administered by the U.S. Department of the Treasury (OFAC), export control regulations (EAR/ITAR), the Foreign Corrupt Practices Act and federal procurement regulations.
She also has experience assisting clients in unfair trade practice disputes, including antidumping and countervailing duty proceedings, CFIUS/Exon-Florio examinations of foreign investment, and trade compliance due diligence in corporate transactions.
New York
Rachel represents clients in high-stakes, complex litigation. She has argued successfully in federal and state appellate courts and has been the lead drafter of briefs and dispositive motions in both state and federal court and the U.S. Supreme Court. Rachel’s experience litigating and advising clients covers a wide range of substantive areas. She focuses in particular on tough questions of constitutional law, statutory interpretation, and intellectual property. Rachel also maintains an active pro bono practice.
Prior to joining Orrick, Rachel served as a law clerk to Supreme Court Justice Stephen G. Breyer, Judge Cornelia T.L. Pillard of the D.C. Circuit, and Judge William A. Fletcher of the Ninth Circuit. Rachel received her J.D. from Yale Law School, where she served as a student director of the Supreme Court Advocacy Clinic and as Essays Editor of the Yale Law Journal. She graduated from Williams College and received master’s degrees from University College London and University of St. Andrews, which she attended as a Marshall Scholar.
New York
Marc represents clients in federal and state court at the trial and appellate levels with a particular focus on class actions, multi-district litigation, and mass joinders. Among Marc’s current engagements, he represents Johns Hopkins University and Teachers Insurance and Annuity Association of America in over a dozen class actions arising out of a data breach of the MOVEit file transfer software; University of Washington in a pandemic-related class action seeking refunds of tuition and fees on behalf of students; ZoomInfo Technologies LLC in a data privacy class action alleging unlawful disclosure of personal information under federal and state laws; Goldman Sachs in a pay and promotion gender discrimination class action; NCAA in concussion and injury-related cases throughout the country; Marathon Oil Corporation in nationwide climate change litigation; and multiple foreign defendants in a class action arising out of allegedly defective drywall.
Recently, Marc successfully prevailed at trial before the Delaware Chancery Court and earned Litigator of the Week recognition by Law.com for defeating claims by Netflix star Julia Haart that she owns half the shares of Elite World Group; secured dismissal of a dozen class actions against the University of California and Santa Clara University brought by students seeking refunds of tuition and fees due to COVID-driven transition to remote instruction; and defeated class certification and secured affirmance on appeal by the Ninth Circuit in an employment discrimination class action against Microsoft.
Marc served as a law clerk to Judge Betty B. Fletcher of the U.S. Court of Appeals for the Ninth Circuit. Prior to joining Orrick, Marc worked as an appellate and post-conviction attorney for the Equal Justice Initiative. In that capacity, he engaged in trial level and appellate representation of clients in both state and federal court, including two cases that were briefed and argued before the United States Supreme Court.
Los Angeles; New York
Los Angeles; New York
Gaelyn has represented a wide range of financial institutions including fund sponsors, issuers, underwriters, placement agents, investment advisers and investors in connection with a wide range of financing transactions including collateralized loan, bond and debt obligations; synthetic collateralized debt obligations; trade receivables; various derivative instruments and structured finance products; and private equity funds and hedge funds.